Ceribell vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
Ceribell (Nasdaq: CBLL) makes the only FDA-cleared AI point-of-care EEG for seizure detection in all patient ages; reported $89.1M revenue in 2025 (+36% YoY) with 2026 guidance of $111–$115M.
About
Ceribell is a commercial-stage medical technology company that has reimagined the electroencephalogram (EEG) for the acute care setting. Its flagship product is a rapid-application, disposable EEG system with an AI algorithm called Clarity that detects electrographic seizures in real time. The platform is FDA-cleared for use across all patient ages — from pre-term neonates through adults — making it the only point-of-care EEG with that breadth of clearance. In December 2025, Ceribell received additional FDA 510(k) clearance for its AI-powered delirium monitoring solution, the first and only FDA-cleared delirium screening and monitoring device.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.